Academic · Private company
Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
Track this companyFree. Adds Pharmacotherapies for Alcohol and Substance Use Disorders Alliance to your Dealase workspace and tells you when its record changes.
Clinical trials52 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials5
- Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient StudyPHASE1 · RECRUITING · started Jul 28, 2025ClinicalTrials.gov NCT06335407 · fetched Nov 12, 2026
- Suvorexant for Treatment of AUD and PTSDPHASE2 · RECRUITING · started Jul 16, 2025ClinicalTrials.gov NCT06679062 · fetched Nov 12, 2026
- Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction StudyPHASE1 · COMPLETED · started Nov 9, 2021ClinicalTrials.gov NCT04827056 · fetched Nov 12, 2026
- Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in VeteransPHASE2 · COMPLETED · started Mar 9, 2021ClinicalTrials.gov NCT04360681 · fetched Nov 12, 2026
- Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSDPHASE2 · TERMINATED · started May 20, 2019ClinicalTrials.gov NCT03852628 · fetched Nov 12, 2026